GSK Investigational Site — Binghamton, New York

GSK Investigational Site is a clinical research site located in Binghamton, New York, United States 13901.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 15 clinical trials with 1 currently active.

Therapeutic areas: Neoplasms, Prostate, Influenza, Diabetes Mellitus, Type 2.

Sponsors: GlaxoSmithKline.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 15 clinical trials on record, with 1 currently active. Their work covers Neoplasms, Prostate, Influenza, Diabetes Mellitus, Type 2.

Is GSK Investigational Site accredited by Crixeo Health?

Yes — GSK Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.